We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
In Module 4, APPs will learn about insurer-mandated switching to biosimilars and how to effectively communicate with the patient. This module provides tools and resources to support patient switching, explains the nocebo effect, and reinforces health literacy and resources to support patients.
Speakers:
Ross M Maltz, MD
Pediatric Gastroenterologist
Nationwide Children’s Hospitial, Director of Very Early Onset Inflammatory Bowel Disease Program
Columbus, OH
This program made possible in part by:
In Module 4, APPs will learn about insurer-mandated switching to biosimilars and how to effectively communicate with the patient. This module provides tools and resources to support patient switching, explains the nocebo effect, and reinforces health literacy and resources to support patients.
Speakers:
Ross M Maltz, MD
Pediatric Gastroenterologist
Nationwide Children’s Hospitial, Director of Very Early Onset Inflammatory Bowel Disease Program
Columbus, OH
This program made possible in part by:
Stay current with the best on medical education
